Molecular Mechanistic insights into the treatment of Myocardial hypertrophy: Epigallocatechin-3-gallate (EGCG), the major componet of Green tea, inhibits Angiotensin II-Induced myocardial hypertrophy via down regulation of ATG9A expression and autophagic activity, 16/April/2014, 14,45

Molecular Mechanistic insights into the treatment of Myocardial hypertrophy: δ-tocotrienol (Vitamin-E) inhibits Angiotensin II-Induced myocardial hypertrophy via down regulation of ATG9A expression and autophagic activity, 16/April/2014, 14,43
April 16, 2014
Molecular Mechanistic insights into the treatment of Myocardial hypertrophy: Rhamnetin, an O-methylated flavonoid and anti-inflammatory agent, inhibits Angiotensin II-Induced myocardial hypertrophy via down regulation of ATG9A expression and autophagic activity, 16/April/2014, 14,48
April 16, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular Mechanistic insights into the treatment of Myocardial hypertrophy: Epigallocatechin-3-gallate (EGCG), the major componet of Green tea,  inhibits Angiotensin II-Induced myocardial hypertrophy via down regulation of ATG9A expression and autophagic activity, 16/April/2014, 14,45, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.